The program in Environmental and Molecular Carcinogenesis integrates investigators from several different departments on 4 distinct NYU campuses: Sterling Forest (14), the School of Medicine (24), Dental School (3) and Washington Square (2) sharing a common interest in understanding the Environmental causes of cancer. The overall goal of the program is to understand the environmental etiology of cancer and to use this information for cancer prevention and early detection. This research program focuses on: (1)The mechanisms of action by environmental carcinogens by investigating their effects on the structure and function of cellular macromolecules. Macromolecules of interest include DNA and proteins, particularly those involved with signaling, transcription control, and susceptibility to environmental agents. These studies are carried out in humans, as well as in vivo and in vitro models. (2) Inorganic compounds, such as arsenic, nickel, chromium, and iron. The molecular toxicological effects of metals and other agents are studied by examining their interactions with DNA and with proteins, which have structural, regulatory or enzymatic activities. (3) The formation of reactive oxygen species, their biochemistry, and the biological effects that might result from their actions. (4) The mutational specificity of carcinogens and site-specific mutagenesis of particular DNA lesions, the molecular basis for genetic susceptibility to environmental agents, the effects of hormones on gene expression and carcinogenesis, and chemoprevention. (5) Epigenetic mechanisms of carcinogenesis. (6) Antioxidants and the prevention of tumor formation as well as developing biomarkers for early detection of cancer. (7) Epidemiology and molecular epidemiology approaches to cancer etiology. Research in this program is divided thematically into five groups: 1) DNA adducts, DNA Damage and Repair; 2) Carcinogenesis and Animal Models;3) Chemoprevention;4) Cell Signaling and Epigenetic Mechanisms of Carcinogenesis;and 5) Early Detection and Cancer Epidemiology.Dr Costa is the Director of the Program. ? Total funding increased from $7,668,974 to $22,551,198. Membership has increased from 21 to 47. Total publications include 627 of which 12% are intra-programmatic and 8% are inter-programmatie.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-32
Application #
8376772
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2013-02-28
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
32
Fiscal Year
2012
Total Cost
$27,944
Indirect Cost
$13,399
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Snetkova, Valentina; Skok, Jane A (2018) Enhancer talk. Epigenomics 10:483-498
Litwinoff, Evelyn M S; Gold, Merav Y; Singh, Karan et al. (2018) Myeloid ATG16L1 does not affect adipose tissue inflammation or body mass in mice fed high fat diet. Obes Res Clin Pract 12:174-186
Lee, Chul-Hwan; Holder, Marlene; Grau, Daniel et al. (2018) Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2. Mol Cell 70:435-448.e5
Fan, Xiaozhou; Alekseyenko, Alexander V; Wu, Jing et al. (2018) Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67:120-127
Gregory, Ann C; Sullivan, Matthew B; Segal, Leopoldo N et al. (2018) Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome. Respir Res 19:174
Taylor, Martin S; Altukhov, Ilya; Molloy, Kelly R et al. (2018) Dissection of affinity captured LINE-1 macromolecular complexes. Elife 7:
Bertrand, Anne; Baron, Maria; Hoang, Dung M et al. (2018) In Vivo Evaluation of Neuronal Transport in Murine Models of Neurodegeneration Using Manganese-Enhanced MRI. Methods Mol Biol 1779:527-541
Jung, Seungyoun; Allen, Naomi; Arslan, Alan A et al. (2018) Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer 142:262-270
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Kirkling, Margaret E; Cytlak, Urszula; Lau, Colleen M et al. (2018) Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep 23:3658-3672.e6

Showing the most recent 10 out of 1170 publications